KMT2D deficiency confers a therapeutic vulnerability to glycolytic and IGFR inhibitors in melanoma
Author:
Affiliation:
1. Department of Genomic Medicine, University of Texas Md Anderson Cancer Center, Houston, TX, USA
Funder
National Cancer Institute
Publisher
Informa UK Limited
Subject
Cancer Research,Molecular Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/23723556.2021.1984827
Reference10 articles.
1. Issue Information
2. Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma
3. Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma
4. Interplay between the Cancer Genome and Epigenome
5. Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Roles of Lysine Methylation in Glucose and Lipid Metabolism: Functions, Regulatory Mechanisms, and Therapeutic Implications;Biomolecules;2024-07-19
2. Epigenomic Markers in Dermato-oncology Immune Landscape;Interdisciplinary Cancer Research;2023
3. Genomic landscape of locally advanced or metastatic urothelial carcinoma with squamous differentiation compared to pure urothelial carcinoma;Urologic Oncology: Seminars and Original Investigations;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3